Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) was upgraded by research analysts at Cantor Fitzgerald to a “strong-buy” rating in a report released on Thursday,Zacks.com reports.
Several other equities research analysts have also recently issued reports on PURR. Wall Street Zen raised Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Weiss Ratings started coverage on Hyperliquid Strategies in a research note on Monday, March 2nd. They set a “sell (e)” rating for the company. Finally, Chardan Capital raised their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research note on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $7.23.
View Our Latest Research Report on Hyperliquid Strategies
Hyperliquid Strategies Stock Performance
Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) last posted its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share (EPS) for the quarter. The business had revenue of $0.50 million during the quarter.
Institutional Investors Weigh In On Hyperliquid Strategies
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PURR. Boothbay Fund Management LLC purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth $40,000. XTX Topco Ltd purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth $48,000. Squarepoint Ops LLC purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth $73,000. Millennium Management LLC purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth $87,000. Finally, Ikarian Capital LLC purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth $107,000. Institutional investors and hedge funds own 9.45% of the company’s stock.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Featured Stories
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
